A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC).

Clinical trial NCT00863746 · COMPLETED

Trial details

NCT number: NCT00863746
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma Non-Small-Cell Lung

Start date: 2009-04-01
Primary completion: 2012-03-01
Enrollment: 703

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.